MBOT

+ Watchlist + Portfolio

Microbot Medical Inc.

GridBrain — Sign in

GridSentinel — Sign in

GridAegis — Sign in

Key Metrics

Previous Close: $1.55
52-Week Range: $1.44 – $4.67
Market Cap: $100.08M
P/E (TTM): —
EPS (TTM): -0.24
Dividend Yield: —

Advanced Metrics

Price/Book: 1.45
PEG Ratio: 0.70
Return on Equity: -32.91%
Return on Assets: -21.72%
Gross Margin: -185.26%
Operating Margin: -2567.63%
Profit Margin: 0.00%
Current Ratio: 18.56
Debt/Equity: 0.01
Total Debt: $876.00K
Free Cash Flow: $-14.24M
Revenue Growth: —
Earnings Growth: —
Enterprise Value: $33.58M

MBOT Income statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Revenue	$0.00	$0.00	$0.00	$0.00
Research & Development	$7.74M	$5.72M	$6.63M	$6.28M
Selling, General & Admin	$5.58M	$4.32M	$4.92M	$8.25M
Operating Expenses	$13.44M	$10.14M	$11.63M	$14.74M
Operating Income	-$13.44M	-$10.14M	-$11.63M	-$14.74M
EBITDA	-$13.34M	-$10.03M	-$11.53M	-$14.70M
Pretax Income	-$13.17M	-$10.74M	-$11.44M	-$13.14M
Net Income	-$13.17M	-$10.74M	-$11.44M	-$13.14M
Diluted EPS	-1.81	-1.05	-0.73	-0.29
Diluted Shares	7.26M	10.20M	15.64M	45.79M

MBOT Balance Sheet statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Cash & Equivalents	$2.44M	$2.47M	$3.11M	$3.91M
Receivables	$532.00K	$1.49M	$300.00K	$644.00K
Inventory	—	—	$0.00	$584.00K
Current Assets	$8.81M	$7.92M	$5.82M	$79.82M
Total Assets	$9.54M	$8.33M	$6.03M	$81.54M
Current Liabilities	$2.07M	$3.79M	$2.46M	$3.42M
Total Debt	$462.00K	$231.00K	$111.00K	$865.00K
Total Liabilities	$2.25M	$3.83M	$2.50M	$3.99M
Retained Earnings	-$68.76M	-$79.50M	-$90.94M	-$104.09M
Shareholders' Equity	$7.29M	$4.50M	$3.53M	$77.55M
Working Capital	$6.75M	$4.13M	$3.36M	$76.40M

MBOT Cash Flow statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Operating Cash Flow	-$11.55M	-$8.53M	-$8.83M	-$13.05M
Capital Expenditure	-$84.00K	-$33.00K	-$25.00K	-$60.00K
Free Cash Flow	-$11.63M	-$8.57M	-$8.85M	-$13.11M
Depreciation & Amortisation	$102.00K	$106.00K	$91.00K	$47.00K
Stock-Based Compensation	$1.75M	$1.39M	$1.35M	$1.06M
Investing Cash Flow	-$3.84M	$1.97M	$1.54M	-$72.38M
Financing Cash Flow	$4.32M	$6.56M	$7.94M	$86.24M
Net Change in Cash	-$11.06M	-$2.00K	$646.00K	$810.00K

MBOT Income statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Revenue	$0.00	$0.00	$0.00	$0.00	$105.00K
Cost of Revenue	$0.00	—	—	—	$103.00K
Gross Profit	$0.00	—	—	—	$2.00K
Research & Development	$1.46M	$2.11M	$1.17M	$1.54M	$1.29M
Selling, General & Admin	$1.56M	$1.61M	$2.69M	$2.38M	$3.03M
Operating Expenses	$3.02M	$3.72M	$3.86M	$4.14M	$4.32M
Operating Income	-$3.02M	-$3.72M	-$3.86M	-$4.14M	-$4.32M
EBITDA	-$3.01M	-$3.71M	-$3.85M	-$4.13M	-$4.31M
Pretax Income	-$2.60M	-$3.50M	-$3.58M	-$3.46M	-$3.67M
Net Income	-$2.60M	-$3.50M	-$3.58M	-$3.46M	-$3.67M
Diluted EPS	-0.08	-0.10	-0.07	—	-0.05
Diluted Shares	31.09M	36.49M	48.10M	—	67.16M

MBOT Balance Sheet statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Cash & Equivalents	$3.22M	$4.08M	$6.70M	$3.91M	$3.66M
Receivables	—	—	—	$644.00K	$105.00K
Inventory	—	—	—	$584.00K	$2.26M
Current Assets	$30.66M	$32.89M	$80.78M	$79.82M	$76.53M
Total Assets	$30.89M	$33.13M	$81.76M	$81.54M	$78.07M
Current Liabilities	$1.89M	$2.73M	$2.93M	$3.42M	$3.39M
Total Debt	$138.00K	$149.00K	$899.00K	$865.00K	$898.00K
Total Liabilities	$1.94M	$2.77M	$3.54M	$3.99M	$3.96M
Retained Earnings	-$93.55M	-$97.05M	-$100.62M	-$104.09M	-$107.76M
Shareholders' Equity	$28.95M	$30.36M	$78.22M	$77.55M	$74.11M
Working Capital	$28.76M	$30.16M	$77.85M	$76.40M	$73.14M

MBOT Cash Flow statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Operating Cash Flow	-$2.87M	-$2.57M	-$3.84M	-$3.76M	-$5.05M
Capital Expenditure	-$13.00K	-$9.00K	-$13.00K	-$25.00K	-$108.00K
Free Cash Flow	-$2.89M	-$2.58M	-$3.85M	-$3.78M	-$5.16M
Depreciation & Amortisation	$15.00K	$12.00K	$10.00K	$10.00K	$12.00K
Stock-Based Compensation	$256.00K	$237.00K	$328.00K	$236.00K	$222.00K
Investing Cash Flow	-$24.83M	-$1.31M	-$44.71M	-$1.53M	$5.00M
Financing Cash Flow	$27.81M	$4.75M	$51.18M	$2.51M	$0.00
Net Change in Cash	$102.00K	$870.00K	$2.62M	-$2.79M	-$56.00K

Market Snapshot

About

Microbot Medical Inc. develops micro-robotic surgical systems for minimally invasive procedures. The company focuses on precision robotic devices that operate inside the human body, targeting applications in cardiology, urology, and other medical fields. Their flagship technology enables surgeons to perform complex procedures through natural pathways, reducing patient trauma and recovery time.